Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Tang J 

PROVIDER: S-EPMC10491910 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature